학술논문

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 26 September 2023, 7(18):5579-5585)
Subject
Language
English
ISSN
24739537
24739529